Quzyttir Injection
Product Images NDC 68118-100

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Quzyttir (NDC 68118-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Esteve Pharmaceuticals, S.a., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vial Label (005p2180101 Bat Zano Uk Etiquette 08feb2021 V02 Current Container Label Page 1)

Packaging label for Zanosar 1 g powder for concentrate for solution for infusion by ESTEVE PHARMACEUTICALS, S.A. The label highlights the active ingredient Streptozocin and specifies intravenous use for single use only, with a cytotoxic warning. The label includes a barcode and color references for printing.*

FDA Label Image

Carton Label (005s5135100 Bat Zano Uk Etui 27aug2018 V01 Current Carton Label)

Packaging label for Zanosar 1g powder for concentrate for solution for infusion. The label shows a white background with a large magenta square and the product name Zanosar in white text within the square. Strength is indicated as 1g, and the active ingredient is Streptozocin. The label states it contains 1 vial and is cytotoxic. Storage instructions, disposal precautions, and a statement of active substance and ingredients are included. The labeler is Keocyt, with marketing authorization details and a barcode also visible.*

FDA Label Image

Dhcp-1 (Dhcp Zanosar 10 10 22 Signed Ek Page 1)

A letter from Esteve Pharmaceuticals S.A.S dated October 10, 2022, addressing healthcare professionals about the temporary importation of non-FDA approved Zanosar (Streptozocin powder for concentrate for solution for infusion) due to a shortage in the U.S. The letter highlights differences between the FDA-approved U.S. product and the imported product, including pharmaceutical form and marketing authorization numbers, and advises referring to the FDA-approved package insert for dosage information. It also mentions storage requirements and therapeutic indication.*

FDA Label Image

Dhcp-2 (Dhcp Zanosar 10 10 22 Signed Ek Page 2)

Table comparing FDA-approved Zanosar and imported versions, showing container labels for 1 gram sterile powder vials, shelf life differences (18 months US, 36 months imported), indications, and administration details including intravenous use.*

FDA Label Image

Dhcp-3 (Dhcp Zanosar 10 10 22 Signed Ek Page 3)

Table comparing FDA-approved U.S. Zanosar and unapproved imported product reconstitution instructions and storage conditions. The U.S. product uses 9.5 mL of dextrose or 0.9% sodium chloride injection for reconstitution, stable up to 12 hours. The imported product requires reconstitution with 9.5 mL sodium chloride 9 mg/mL (0.9%) solution, should be immediately diluted, and stable for 24 hours below 25°C in polyethylene bags. Additional text below provides details on barcode accuracy, packaging serialization, company changes, and contact information for ESTEVE Pharmaceuticals S.A.*

FDA Label Image

Dhcp-4 (Dhcp Zanosar 10 10 22 Signed Ek Page 4)

This document excerpt from ESTEVE PHARMACEUTICALS, S.A. includes instructions for reporting adverse events or quality problems to the FDA's MedWatch program online, by mail, or fax. It lists contact details for submitting reports and contains a signature block for the Chief Pharmaceuticals Officer, Eugénie Koubbi, with company address and phone/fax contact information at the bottom.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.